RBP4 may downregulate PGC-1α and affect transcription factors involved in fiber type specification (Lin et al., 2005), reducing oxidative capacity and impairing endurance, which may affect muscle performance and contribute to fatigue in metabolic disorders. Here, RBP4 is linked to Other metabolic disease.